HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging.

Abstract
The Enhanced Permeability and Retention (EPR) effect is extensively used in drug delivery research. Taking into account that EPR is a highly variable phenomenon, we have here set out to evaluate if contrast-enhanced functional ultrasound (ceUS) imaging can be employed to characterize EPR-mediated passive drug targeting to tumors. Using standard fluorescence molecular tomography (FMT) and two different protocols for hybrid computed tomography-fluorescence molecular tomography (CT-FMT), the tumor accumulation of a ~10 nm-sized near-infrared-fluorophore-labeled polymeric drug carrier (pHPMA-Dy750) was evaluated in CT26 tumor-bearing mice. In the same set of animals, two different ceUS techniques (2D MIOT and 3D B-mode imaging) were employed to assess tumor vascularization. Subsequently, the degree of tumor vascularization was correlated with the degree of EPR-mediated drug targeting. Depending on the optical imaging protocol used, the tumor accumulation of the polymeric drug carrier ranged from 5 to 12% of the injected dose. The degree of tumor vascularization, determined using ceUS, varied from 4 to 11%. For both hybrid CT-FMT protocols, a good correlation between the degree of tumor vascularization and the degree of tumor accumulation was observed, within the case of reconstructed CT-FMT, correlation coefficients of ~0.8 and p-values of <0.02. These findings indicate that ceUS can be used to characterize and predict EPR, and potentially also to pre-select patients likely to respond to passively tumor-targeted nanomedicine treatments.
AuthorsBenjamin Theek, Felix Gremse, Sijumon Kunjachan, Stanley Fokong, Robert Pola, Michal Pechar, Roel Deckers, Gert Storm, Josef Ehling, Fabian Kiessling, Twan Lammers
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 182 Pg. 83-9 (May 28 2014) ISSN: 1873-4995 [Electronic] Netherlands
PMID24631862 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Acrylamides
  • Contrast Media
  • Enbucrilate
Topics
  • Acrylamides (administration & dosage)
  • Animals
  • Blood Volume
  • Cell Line, Tumor
  • Contrast Media (administration & dosage)
  • Drug Delivery Systems
  • Enbucrilate
  • Mice, Nude
  • Microbubbles
  • Neoplasms (blood supply, diagnostic imaging, metabolism, physiopathology)
  • Permeability
  • Regional Blood Flow
  • Tomography (methods)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: